ARDX
Ardelyx, Inc.NASDAQHealthcare$5.94-2.78%ClosedMarket Cap: $1.46B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
8.71
P/S
3.59
EV/EBITDA
-55.11
DCF Value
$-221.00
FCF Yield
-3.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
90.3%
Operating Margin
-10.1%
Net Margin
-15.1%
ROE
-40.6%
ROA
-12.3%
ROIC
-9.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $125.2M | 89.2% | $5.1M | $-407.0K | $-0.00 | — |
| FY 2025 | $407.3M | 90.3% | $-41.0M | $-61.6M | $-0.26 | — |
| Q3 2025 | $110.3M | 98.8% | $4.7M | $-969.0K | $-0.00 | — |
| Q2 2025 | $97.7M | 87.3% | $-14.4M | $-19.1M | $-0.08 | — |
| Q1 2025 | $74.1M | 83.4% | $-36.3M | $-41.1M | $-0.17 | — |
| Q4 2024 | $116.1M | 84.3% | $8.1M | $4.6M | $0.02 | — |
| FY 2024 | $333.6M | 84.8% | $-27.9M | $-39.1M | $-0.17 | — |
| Q3 2024 | $98.2M | 84.0% | $2.2M | $-809.0K | $-0.00 | — |
| Q2 2024 | $73.2M | 86.3% | $-13.6M | $-16.5M | $-0.07 | — |
| Q1 2024 | $46.0M | 83.6% | $-24.7M | $-26.5M | $-0.11 | — |
| Q4 2023 | $34.4M | 85.2% | $-28.0M | $-28.8M | $-0.12 | — |
| FY 2023 | $124.5M | 85.7% | $-63.3M | $-66.1M | $-0.30 | — |